Jeffrey Ravetch, M.D., Ph.D.

Jeffrey V. Ravetch, M.D., Ph.D. is currently the Theresa and Eugene Lang Professor at the
Rockefeller University and Head of the Leonard Wagner Laboratory of Molecular Genetics and
Immunology.

Dr. Ravetch, a native of New York City, earned degrees from Yale University, Cornell Medical
College and The Rockefeller University and pursued postdoctoral studies at the NIH. From 1982
to 1996 Dr. Ravetch was a member of the faculty of Memorial Sloan-Kettering Cancer Center
and Cornell Medical College. His laboratory has focused on the Fc domain of antibodies and
their receptors, establishing their structural and functional diversity and the pre-eminence of FcR
pathways in host defense, inflammation and tolerance. His work has been widely extended into
clinical applications for the treatment of neoplastic, inflammatory and infectious diseases.

Dr. Ravetch has received numerous awards including the William B. Coley Award (2007),
Sanofi-Pasteur Award (2012), Gairdner International Prize (2012), Wolf Prize in Medicine
(2015), Ross Prize in Molecular Medicine (2017) and the Robert Koch award (2018). He is a
member of National Academy of Sciences (2006), the National Academy of Medicine (2007), a
Fellow of the American Academy of Arts and Sciences (2008) and a Fellow of the American
Association for the Advancement of Science (2009).

Ravetch has contributed extensively to the scientific community by serving as a member of the
Scientific Advisory Boards of the Cancer Research Institute, the Irvington Institute for Medical
Research, the Damon Runyon Foundation, the medical advisory board of Gairdner Foundation,
the Sanofi-Pasteur Award Jury and the L’Oreal Women in Science Jury. He has been active in
biotechnology for the last two decades, and currently serves as a consultant or member of the
Scientific Advisory Boards of Harpoon, Kleo, Momenta, Palleon, Portola and Xencor.